MEDIROM Healthcare Technologies Inc. (MRM) Revenue History
Annual and quarterly revenue from 2018 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
MRM Revenue Growth
Revenue Breakdown (FY 2024)
MRM's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
MRM Revenue Analysis (2018–2024)
As of May 8, 2026, MEDIROM Healthcare Technologies Inc. (MRM) generated trailing twelve-month (TTM) revenue of $11.91 billion, reflecting significant decline in growth of -99.4% year-over-year. The most recent quarter (Q2 2025) recorded $21.9 million in revenue, down 99.5% sequentially.
Looking at the longer-term picture, MRM's 5-year compound annual growth rate (CAGR) stands at +16.3%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $8.30 billion in 2024, representing a new all-time high.
Revenue diversification analysis shows MRM's business is primarily driven by Franchise (26%), Sublease revenue (26%), and Other franchise revenues (15%).
When compared to Consumer Cyclical sector peers including XPOF (-6.1% YoY), PLNT (+14.4% YoY), and HIMS (+59.0% YoY), MRM has underperformed the peer group in terms of revenue growth. Compare MRM vs XPOF →
MRM Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| MRMCurrent | $11.9B | -99.4% | +16.3% | -0.2% | |
 XPOF | $315M | -6.1% | +24.2% | 25.3% | |
 PLNT | $1.3B | +14.4% | +26.6% | 29.8% | |
 HIMS | $2.3B | +59.0% | +73.6% | 5.2% | |
 ACMR | $901M | +15.2% | +41.9% | 12.1% |
MRM Historical Revenue Data (2018–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $8.30B | +21.5% | $2.25B | 27.1% | $-18,102,000 | -0.2% |
| 2023 | $6.83B | -1.8% | $1.57B | 23.0% | $-391,579,000 | -5.7% |
| 2022 | $6.95B | +28.5% | $1.90B | 27.4% | $97.0M | 1.4% |
| 2021 | $5.41B | +61.9% | $1.42B | 26.2% | $-470,587,000 | -8.7% |
| 2020 | $3.34B | -14.5% | $428.9M | 12.8% | $-746,088,000 | -22.3% |
| 2019 | $3.91B | +13.8% | $950.8M | 24.3% | $78.9M | 2.0% |
| 2018 | $3.43B | - | $956.9M | 27.9% | $114.0M | 3.3% |
See MRM's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MRM Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MRM vs AMZN
Side-by-side business, growth, and profitability comparison vs Amazon.com, Inc..
Start ComparisonMRM — Frequently Asked Questions
Quick answers to the most common questions about buying MRM stock.
Is MRM's revenue growth accelerating or slowing?
MRM revenue declined -99.4% year-over-year, contrasting with the 5-year CAGR of +16.3%. TTM revenue fell to $11.9B. This reverses the prior growth trend.
What is MRM's long-term revenue growth rate?
MEDIROM Healthcare Technologies Inc.'s 5-year revenue CAGR of +16.3% reflects the variable expansion pattern. Current YoY growth of -99.4% is below this long-term average.
How is MRM's revenue distributed by segment?
MRM reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2018-2024 are available for download. Segment mix reveals concentration and diversification trends.